Related references
Note: Only part of the references are listed.STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases
Tiziana Lorenzini et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Julie Toubiana et al.
BLOOD (2016)
Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation
Ali Sobh et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1
Safa Baris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
Treatment options for chronic mucocutaneous candidiasis
Frank L. van de Veerdonk et al.
JOURNAL OF INFECTION (2016)
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
Jie Zheng et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
Eleanor Higgins et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Immune defence against Candida fungal infections
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome
Gulbu Uzel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival
Neil Romberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe
Beata Soltesz et al.
JOURNAL OF MEDICAL GENETICS (2013)
Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
Kiyoshi Hirahara et al.
IMMUNITY (2012)
Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology
Jordan S. Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
Luyan Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
Frank L. van de Veerdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa
S. A. Khader et al.
MUCOSAL IMMUNOLOGY (2009)
Structural bases of unphosphorylated STAT1 association and receptor binding
X Mao et al.
MOLECULAR CELL (2005)
Share Paper
